Correlating Cystic Fibrosis Transmembrane Conductance Regulator Function with Clinical Features to Inform Precision Treatment of Cystic Fibrosis

Allison F McCague, Karen S Raraigh, Matthew J Pellicore, Emily F Davis-Marcisak, Taylor A Evans, Sangwoo T Han, Zhongzhou Lu, Anya T Joynt, Neeraj Sharma, Carlo Castellani, Joseph M Collaco, Mary Corey, Michelle H Lewis, Chris M Penland, Johanna M Rommens, Anne L Stephenson, Patrick R Sosnay, Garry R Cutting

Research output: Contribution to journalArticle

Abstract

Rationale: The advent of precision treatment for cystic fibrosis using small-molecule therapeutics has created a need to estimate potential clinical improvements attributable to increases in cystic fibrosis transmembrane conductance regulator (CFTR) function. Objectives: To derive CFTR function of a variety of CFTR genotypes and correlate with key clinical features (sweat chloride concentration, pancreatic exocrine status, and lung function) to develop benchmarks for assessing response to CFTR modulators. Methods: CFTR function assigned to 226 unique CFTR genotypes was correlated with the clinical data of 54,671 individuals enrolled in the Clinical and Functional Translation of CFTR (CFTR2) project. Cross-sectional FEV1% predicted measurements were plotted by age at which measurement was obtained. Shifts in sweat chloride concentration and lung function reported in CFTR modulator trials were compared with function-phenotype correlations to assess potential efficacy of therapies. Measurements and Main Results: CFTR genotype function exhibited a logarithmic relationship with each clinical feature. Modest increases in CFTR function related to differing genotypes were associated with clinically relevant improvements in cross-sectional FEV1% predicted over a range of ages (6-82 yr). Therapeutic responses to modulators corresponded closely to predictions from the CFTR2-derived relationship between CFTR genotype function and phenotype. Conclusions: Increasing CFTR function in individuals with severe disease will have a proportionally greater effect on outcomes than similar increases in CFTR function in individuals with mild disease and should reverse a substantial fraction of the disease process. This study provides reference standards for clinical outcomes that may be achieved by increasing CFTR function.

Original languageEnglish
Pages (from-to)1116-1126
Number of pages11
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume199
Issue number9
DOIs
Publication statusPublished - May 1 2019

Keywords

  • Adolescent
  • Adult
  • Child
  • Cystic Fibrosis/genetics
  • Cystic Fibrosis Transmembrane Conductance Regulator/genetics
  • Female
  • Forced Expiratory Volume
  • Genetic Association Studies
  • Humans
  • Male
  • Middle Aged
  • Precision Medicine/methods
  • Young Adult

Fingerprint Dive into the research topics of 'Correlating Cystic Fibrosis Transmembrane Conductance Regulator Function with Clinical Features to Inform Precision Treatment of Cystic Fibrosis'. Together they form a unique fingerprint.

  • Cite this

    McCague, A. F., Raraigh, K. S., Pellicore, M. J., Davis-Marcisak, E. F., Evans, T. A., Han, S. T., Lu, Z., Joynt, A. T., Sharma, N., Castellani, C., Collaco, J. M., Corey, M., Lewis, M. H., Penland, C. M., Rommens, J. M., Stephenson, A. L., Sosnay, P. R., & Cutting, G. R. (2019). Correlating Cystic Fibrosis Transmembrane Conductance Regulator Function with Clinical Features to Inform Precision Treatment of Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine, 199(9), 1116-1126. https://doi.org/10.1164/rccm.201901-0145OC